Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: LIVER CANCER, . Treffer: 30

2019

Czepukojc, B; Abuhaliema, A; Barghash, A; Tierling, S; Nass, N; Simon, Y; Korbel, C; Cadenas, C; van Hul, N; Sachinidis, A; Hengstler, JG; Helms, V; Laschke, MW; Walter, J; Haybaeck, J; Leclercq, I; Kiemer, AK; Kessler, SM IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis
FRONT MED-LAUSANNE. 2019; 6: 179 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Golob-Schwarzl, N; Friedbichler, K; Kenner, L; Haybaeck, J; Moriggl, R STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
Cytokine. 2018; 154573-154573 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Suske, T; Merkel, O; Kenner, L; Luís, A; Kozlov, A; Haybaeck, J; Müller, M; Han, X; Moriggl, R Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression.
Cytokine. 2018; 154569-154569 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Klec, C; Gutschner, T; Panzitt, K; Pichler, M Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Expert Opin Ther Targets. 2019; 23(3): 177-186.
Web of Science PubMed FullText FullText_MUG

 

Kröhler, T; Kessler, SM; Hosseini, K; List, M; Barghash, A; Patial, S; Laggai, S; Gemperlein, K; Haybaeck, J; Müller, R; Helms, V; Schulz, MH; Hoppstädter, J; Blackshear, PJ; Kiemer, AK The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.
Cancers (Basel). 2019; 11(11): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Matak, A; Lahiri, P; Ford, E; Pabst, D; Kashofer, K; Stellas, D; Thanos, D; Zatloukal, K Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer.
Hepatology. 2018; 68(3):933-948 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Ganten, TM; Stauber, RE; Schott, E; Malfertheiner, P; Buder, R; Galle, PR; Göhler, T; Walther, M; Koschny, R; Gerken, G Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study.
Clin Cancer Res. 2017; 23(19):5720-5728 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nelson, ME; Lahiri, S; Chow, JD; Byrne, FL; Hargett, SR; Breen, DS; Olzomer, EM; Wu, LE; Cooney, GJ; Turner, N; James, DE; Slack-Davis, JK; Lackner, C; Caldwell, SH; Hoehn, KL Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.
Nat Commun. 2017; 8(6):14689-14689 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Reinhardt, M; Brandmaier, P; Seider, D; Kolesnik, M; Jenniskens, S; Sequeiros, RB; Eibisberger, M; Voglreiter, P; Flanagan, R; Mariappan, P; Busse, H; Moche, M; ClinicIMPPACT Study Group A prospective development study of software-guided radio-frequency ablation of primary and secondary liver tumors: Clinical intervention modelling, planning and proof for ablation cancer treatment (ClinicIMPPACT).
Contemp Clin Trials Commun. 2017; 8(5):25-32 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Richtig, G; Aigelsreiter, A; Schwarzenbacher, D; Ress, AL; Adiprasito, JB; Stiegelbauer, V; Hoefler, G; Schauer, S; Kiesslich, T; Kornprat, P; Winder, T; Eisner, F; Gerger, A; Stoeger, H; Stauber, R; Lackner, C; Pichler, M SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
PLoS One. 2017; 12(11):e0187814-e0187814 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Healy, ME; Lahiri, S; Hargett, SR; Chow, JD; Byrne, FL; Breen, DS; Kenwood, BM; Taddeo, EP; Lackner, C; Caldwell, SH; Hoehn, KL Dietary sugar intake increases liver tumor incidence in female mice.
Sci Rep. 2016; 6(10):22292-22292 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lemberger, UJ; Fuchs, CD; Karer, M; Haas, S; Stojakovic, T; Schöfer, C; Marschall, HU; Wrba, F; Taketo, MM; Egger, G; Trauner, M; Österreicher, CH Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease.
Oncotarget. 2016; 7(52):86985-86998 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tang, Y; Fickert, P; Trauner, M; Marcus, N; Blomenkamp, K; Teckman, J Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Am J Physiol Gastrointest Liver Physiol. 2016; 311(1):G156-G165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Egger, J; Busse, H; Brandmaier, P; Seider, D; Gawlitza, M; Strocka, S; Voglreiter, P; Dokter, M; Hofmann, M; Kainz, B; Hann, A; Chen, X; Alhonnoro, T; Pollari, M; Schmalstieg, D; Moche, M Interactive Volumetry Of Liver Ablation Zones.
Sci Rep. 2015; 5(2):15373-15373 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Healy, ME; Chow, JD; Byrne, FL; Breen, DS; Leitinger, N; Li, C; Lackner, C; Caldwell, SH; Hoehn, KL Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.
J Hepatol. 2015; 62(3):599-606 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pfeiffenberger, J; Mogler, C; Gotthardt, DN; Schulze-Bergkamen, H; Litwin, T; Reuner, U; Hefter, H; Huster, D; Schemmer, P; Członkowska, A; Schirmacher, P; Stremmel, W; Cassiman, D; Weiss, KH Hepatobiliary malignancies in Wilson disease.
Liver Int. 2015; 35(5):1615-1622
Web of Science PubMed FullText FullText_MUG

 

2014

Herz, C; Hertrampf, A; Zimmermann, S; Stetter, N; Wagner, M; Kleinhans, C; Erlacher, M; Schüler, J; Platz, S; Rohn, S; Mersch-Sundermann, V; Lamy, E The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
J Cell Mol Med. 2014; 18(12):2393-2403 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kleine, M; Worbs, T; Schrem, H; Vondran, FW; Kaltenborn, A; Klempnauer, J; Förster, R; Josenhans, C; Suerbaum, S; Bektas, H Helicobacter hepaticus induces an inflammatory response in primary human hepatocytes.
PLoS One. 2014; 9(6): e99713-e99713. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Groth, A; Ottinger, S; Kleist, C; Mohr, E; Golriz, M; Schultze, D; Bruns, H; Mehrabi, A; Schemmer, P; Büchler, MW; Herr, I Evaluation of porcine mesenchymal stem cells for therapeutic use in human liver cancer.
Int J Oncol. 2012; 40(2):391-401 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Katz, SF; Lechel, A; Obenauf, AC; Begus-Nahrmann, Y; Kraus, JM; Hoffmann, EM; Duda, J; Eshraghi, P; Hartmann, D; Liss, B; Schirmacher, P; Kestler, HA; Speicher, MR; Rudolph, KL Disruption of Trp53 in livers of mice induces formation of carcinomas with bilineal differentiation.
Gastroenterology. 2012; 142(5):1229-1239
Web of Science PubMed FullText FullText_MUG

 

Min, L; Ji, Y; Bakiri, L; Qiu, Z; Cen, J; Chen, X; Chen, L; Scheuch, H; Zheng, H; Qin, L; Zatloukal, K; Hui, L; Wagner, EF Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.
Nat Cell Biol. 2012; 14(11):1203-1211
Web of Science PubMed FullText FullText_MUG

 

Peck-Radosavljevic, M; Sieghart, W; Kölblinger, C; Reiter, M; Schindl, M; Ulbrich, G; Steininger, R; Müller, C; Stauber, R; Schöniger-Hekele, M; Gschwendtner, M; Plank, C; Funovics, M; Graziadei, I; Lammer, J; Gruenberger, T; Gastl, G; Karnel, F; Austrian Association of Gastroenterology,Hepatology (GGH); Austrian Society of Interventional Radiology (GIR); Austrian Society of Hematology and Oncology (GHO); Austrian Society for Surgical Oncology (ASSO) Austrian Joint GGH-GIR-GHO-ASSO position statement on the use of transarterial chemoembolization (TACE) in hepatocellular carcinoma.
Wien Klin Wochenschr. 2012; 124(3-4):104-110
Web of Science PubMed FullText FullText_MUG

 

2011

Pinter, M; Sieghart, W; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Weissmann, A; Kornek, G; Matejka, J; Stauber, R; Buder, R; Grünberger, B; Schöniger-Hekele, M; Müller, C; Peck-Radosavljevic, M Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib.
Aliment Pharmacol Ther. 2011; 34(8): 949-959. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2010

Rausch, V; Liu, L; Kallifatidis, G; Baumann, B; Mattern, J; Gladkich, J; Wirth, T; Schemmer, P; Büchler, MW; Zöller, M; Salnikov, AV; Herr, I Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Cancer Res. 2010; 70(12):5004-5013 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Vucur, M; Roderburg, C; Bettermann, K; Tacke, F; Heikenwalder, M; Trautwein, C; Luedde, T Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?
Oncotarget. 2010; 1(5):373-378 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText

 

2008

Hui, L; Zatloukal, K; Scheuch, H; Stepniak, E; Wagner, EF Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.
J Clin Invest. 2008; 118(12): 3943-3953. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Sagmeister, S; Eisenbauer, M; Pirker, C; Mohr, T; Holzmann, K; Zwickl, H; Bichler, C; Kandioler, D; Wrba, F; Mikulits, W; Gerner, C; Shehata, M; Majdic, O; Streubel, B; Berger, W; Micksche, M; Zatloukal, K; Schulte-Hermann, R; Grasl-Kraupp, B New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis.
Br J Cancer. 2008; 99(1):151-159 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2007

Panzitt, K; Tschernatsch, MM; Guelly, C; Moustafa, T; Stradner, M; Strohmaier, HM; Buck, CR; Denk, H; Schroeder, R; Trauner, M; Zatloukal, K Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA.
Gastroenterology. 2007; 132(1):330-342
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Schemmer, P; Friess, H; Hinz, U; Mehrabi, A; Kraus, TW; Z'graggen, K; Schmidt, J; Uhl, W; Büchler, MW Stapler hepatectomy is a safe dissection technique: analysis of 300 patients.
World J Surg. 2006; 30(3):419-430
Web of Science PubMed FullText FullText_MUG

 

1982

Polterauer, P; Linkesch, W Serum-alpha 1-fetoprotein and serumferritin in liver tumours (author's transl)
WIEN KLIN WOCHENSCHR. 1982; 94(4): 105-108.
Web of Science PubMed

 

© Med Uni Graz Impressum